Eco R1 Capital, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Eco R1 Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $37.9 Million - $46.7 Million	-519,119 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $6.94 Million - $11.6 Million	147,911 Added 39.85%	519,119 $40.6 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $3.71 Million - $6.9 Million	109,654 Added 41.92%	371,208 $16.5 Million
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $7.22 Million - $9.17 Million	200,000 Added 324.92%	261,554 $11.2 Million
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $18.5 Million - $27.5 Million	-436,345 Reduced 87.64%	61,554 $2.63 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $19.9 Million - $34.5 Million	497,899 New	497,899 $34.5 Million
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $9.88 Million - $19.6 Million	-254,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $18.2 Million - $22.9 Million	254,000 New	254,000 $19.4 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.